LONDON - Polar Capital Global Healthcare Trust plc has disclosed its top ten equity holdings as of November 29, 2024, which comprise 49.2% of its portfolio, with UnitedHealth Group (NYSE:UNH) leading at 8.0%, followed closely by Eli Lilly & Co (NYSE:LLY) at 7.9%. The trust's sector exposure is heavily weighted towards pharmaceuticals and biotechnology, which make up over half of its investments.
The geographic distribution of the trust's investments is predominantly in the United States, accounting for 45.4% of the total exposure, with significant positions also in Switzerland and Denmark. The complete portfolio listing, as of October 31, 2024, is available on the company's website.
The monthly factsheet, including commentary from the investment manager, is expected to be available on the company's website shortly, providing further insights into the trust's strategy and performance. This announcement, based on a press release statement, serves to keep investors informed on the trust's latest portfolio allocations.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.